Our toxicological metabolomics theme lead, Professor Mark Viant, has developed and applied metabolomics in the fields of human and environmental toxicology for over 15 years. Mark is a past President and Lifetime Honorary Fellow of the Metabolomics Society, with a reputation for driving metabolomics forward, and developing excellence in the field.
Mark's work with industry includes long-established collaborators such as Unilever and AstraZeneca, who work with us to better understand and address the chemical safety science 'problem space' within the consumer products and drug discovery sectors.
Mark's work with regulatory agencies and governmental bodies is directed towards finding solutions for regulatory problems, with active collaborations with the European Commission's Joint Research Centre, European Chemicals Agency, Health Canada and the US EPA supporting these goals.
Mark also leads international activities in defining best practice and reporting standards for metabolomics applied to toxicology, including the OECD’s Metabolomics Reporting Framework project.
These activities place Phenome Centre Birmingham in an outstanding position to conduct metabolomics studies in the context of human health, with the group's unique expertise in chemical safety science and regulatory requirements proving invaluable for our collaborator's projects.